OHSU. Vermont s Response to the Opioid Crisis Alumni Scientific Session Dr. Harry Chen Commissioner of Health (former)
|
|
- Vanessa Stanley
- 6 years ago
- Views:
Transcription
1 Vermont s Response to the Opioid Crisis Alumni Scientific Session Dr. Harry Chen Commissioner of Health (former) May 12, 2017
2 The Problem Opioids are powerful and useful pain killers. Opioids are highly addictive. Opioid overdose and addiction is a growing public health problem. Prescribers play a role in the supply and use of opioids in the treatment of pain and addiction in our communities.
3
4 Rolling Stone Magazine 4/3/2014
5 The distribution of morphine consumption in 2009 was highly disproportionate to the general population distribution around the world. SOURCE: International Narcotics Control Board. 5
6 SOURCE: International Narcotics Control Board. 6
7 States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System. Opioid pain reliever sales rate, 2013, DEA s Automation of Reports and Consolidated Orders System 7
8 Doctors are the most common source of opioids for most frequent nonmedical users. SOURCE: Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of pastyear nonmedical use: United States, JAMA Internal Medicine
9 The higher the morphine milligram equivalent, the higher the overdose death hazard. SOURCE: JAMA 2011;305:
10 Patients receiving high doses of opioid pain relievers account for disproportionate share of overdoses. 100% multiple doctors, high doses 90% multiple doctors, one doctor, high dose 80% high doses 70% 60% 50% one doctor, lower dose 40% one doctor, high dose 30% 20% 10% 0% patients receiving opioid pain relievers one doctor, lower dose patients overdosing with opioid pain relievers SOURCE: CDC Grand Rounds: Prescription Drug Overdoses a U.S. Epidemic. MMWR Weekly. January 13, 2012 / 61(01);
11 an epidemic of suicides and afflictions stemming from substance abuse: alcoholic liver disease and overdoses of heroin and prescription opioids.
12 All-cause mortality, ages for US White non-hispanics (USW), US Hispanics (USH), and six comparison countries: France (FRA), Germany (GER), the United Kingdom (UK), Canada (CAN), Australia (AUS), and Sweden (SWE). Anne Case, and Angus Deaton PNAS 2015;112: by National Academy of Sciences
13 Mortality by cause, white non-hispanics ages Anne Case, and Angus Deaton PNAS 2015;112: by National Academy of Sciences
14 Overall Opioid 2015 Death Rate by State Source: CDC Wonder as compiled by the Washington Post
15 Vermont is the Only Northeastern State without a Statistically Significant Increase in Drug Overdose 2014 to 2015 Source: CDC/NCHS, National Vital Statistics System, mortality data. Includes opioids and other drugs.
16 New England Drug Overdose Deaths Connecticut Maine 25 Massachusetts 20 New Hampshire Rhode Island 15 Vermont 10 Deaths per 100, Source: CDC/NCHS, National Vital Statistics System, mortality data. Includes opioids and other drugs
17 Vermont Drug Poisoning Estimated Deaths by County (All Drug Poisoning Deaths) Source: Centers for Disease Control and Prevention, Drug Poisoning Mortality: United States, Vermont s 2014 age adjusted rate of drug poisoning deaths is the same as the U.S. average at approximately 14.7 per 100,000 Vermonters. January 2016
18 Drug-Related Fatalities Involving Opioids Total number of accidental and undetermined manner drug-related fatalities involving an opioid (categories not mutually exclusive) Total opioid Rx opioid Heroin Fentanyl Source: Vital Statistics System
19 Key Surveillance Needs Respond to emerging issues
20 Emergency Department Discharge Data Emergency Department Discharge Rate per 100,000 People for Opioid Overdose, by Type of Opioid and Year Vermont Residents at Vermont Hospitals Other opioids Heroin Source: Vermont Uniform Hospital Discharge Data Set
21 Nationally, over half of those who misused a prescription pain reliever got it from a friend or relative. Source: National Survey on Drug Use and Health,
22 Non-medical use of prescription pain relievers in Vermont Percent of Vermont population reporting non-medical use of pain relievers in the past year by age in years Source: National Survey on Drug Use and Health,
23 Heroin use among high school students remains low Percent of high school students reporting heroin use within their lifetime by year Source: Youth Risk Behavior Survey, 2013 and
24 Opioid Misuse Young Adult Survey* & College Health Survey Percent of young adults who report opioid misuse in the past year by data source Young Adult Survey *Young Adult Survey conducted by the Pacific Institute for Research and Evaluation under a contract with VDH College Health Survey Source: Young Adult Survey and College Health Survey 24
25 In 2012, Vermont had a relatively low number prescriptions per person 25
26 Number of Prescriptions by Drug Type and Year Total Number of Controlled Substance Prescriptions by Drug Type and Year Opioids Sedatives Stimulants Adjusted Opioids 601, , , , , , , , , , , , , , , , , , , Note: The 2015 Annual Report reflects the first full year of VPMS data with tramadol reclassified from a Schedule V to a Schedule IV drug. Its inclusion in VPMS data due to this reclassification resulted in an increase of 82,992 opioid prescriptions being reported to VPMS Additionally, the White River Junction Veterans Affairs Medical Center began uploading to VPMS in March of It uploaded 19,541 opioid prescriptions in Had these two new data sources not been provided to VPMS in 2015, the number of opioid prescriptions would have decreased for the first time since (See the Adjusted Opioids trend line.) 26
27 Prescription histories of Individuals with opioid-related accidental fatalities (ORAF) In 2015, 68 of 75 ORAF individuals had controlled substance prescription histories Of the 68, 81% received high dose (>90 MME) analgesics in the period before their deaths ORAF s with an opioid prescription in the year prior to fatality received average of 261 days supply in that year. % of ORAF with > 90 MME Opioid Rx by Time Elapsed Before Death Vermont Department of Health Source: Vermont Prescription Monitoring System and Vital 27Statistics
28 For every 1 fatal opioid overdose in VT there are: people receiving at least one rx for analgesics 1,482 nonmedical rx pain reliever users needle exchange members 64 EMS overdose calls 18 people receiving at least one MAT service for OUD community opioid reversals emergency department visits for opioids infants born exposed to opioids 5 3 2
29 Actions to Address Opioid Drug Abuse Education Tracking and Regulation/Enforcement Identification verification at Prescriber Monitoring pharmacies education Vermont Prescription Law enforcement training on Community Drug Monitoring System prescription drug misuse and education (VPMS) diversion Naloxone Unified Pain Management distribution Regulation Treatment Options Keeping medications safe at home Care Alliance for Opioid Addiction Proper Medication Disposal Proper medication disposal guidelines consistent with FDA standards Community take-back programs Most Dangerous Leftovers Campaign Regional Treatment Centers Outpatient and residential treatment at state-funded treatment providers Harm Reduction 29
30
31 Regulation MAT Rule Based on DATA 2000 Unified Pain Management Rule (Chronic) VPMS (prescription monitoring) Patient contract Urinalysis requirement Pill counts Referral for risk Acute Pain Rule
32 The Problem As many as four out of five heroin users begin by abusing prescription drugs Of those who abuse prescription opioids, seven out of 10 received these drugs through methods of diversion Opioids are overprescribed. They are prescribed: Too often At too high a dose For too long One in four become addicted. One in 550 die from their opioids Prescribers play a role in the supply and use of opioids in our and use of opioids in communities.
33
34
35 Patient-level surveys of opioid use after surgery Dartmouth Hitchcock researchers examined opioid prescribing patterns after general surgery outpatient procedures. Results: An average of only 28% of pills were used To satisfy 80% of patient needs, could reduce Wide variation in quantity provided for each operation prescription amounts by 43% 1: Hill M, McMahon M, Stucke R, & Barth R. Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Annals of Surgery. 2016; doi: /SLA
36 Patient-level surveys of opioid use after surgery UVM study (Nov. 2016), after general and orthopedic surgery, same wide variation found even within a practice. Results: 7% did not receive an opioid Of the 93% who received an opioid 12% did not fill the prescription 30% that filled the prescription didn t use any The overall median proportion used = 26%
37 New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults Chad M. Brummett, MD1,2; Jennifer F. Waljee, MD, MPH, MS2,3; Jenna Goesling, PhD1; et al JAMA Surg. Published online April 12, doi: /jamasurg Conclusions: In a cohort of previously opioid-naive patients, approximately 6% continued to use opioids more than 3 months after their surgery, and as such, prolonged opioid use is a common postsurgical complication. New persistent opioid use is not different among patients who underwent minor and major surgical procedures, thereby suggesting that prolonged opioid use is not entirely due to surgical pain.
38 Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use Michael L. Barnett, M.D., Andrew R. Olenski, B.S., and Anupam B. Jena, M.D., Ph.D. N Engl J Med 2017; 376: February 16, 2017DOI: /NEJMsa department, and rates of long-term opioid use were Wide variation in rates of opioid prescribing existed among physicians practicing within the same emergency increased among patients who had not previously received opioids and received treatment from high-intensity opioid prescribers.
39 Percent of people getting 50% pain relief (from acute postop pain) 1/NNT From Cochrane Reviews Two 5 mg Percocet pills Ibuprofen 200mg Ibuprofen 400 mg Oxycodone 15 mg Acetaminophen 500 mg Ibu acet 500 Source: Don Teater MD
40 Universal Precautions First consider non-opioid and nonpharmacologic treatments Upon first prescription prescribers must: discuss risks including safe storage and disposal provide a patient education sheet, and receive an informed consent for all first opioid prescriptions Co-prescribe naloxone for prescriptions over 90 MME or if also on benzodiazepines Check the prescription monitoring system for everyone s first prescription exceeding 10 pills or a replacement prescription
41 Opioid Prescribing for Acute Pain First prescription to opioid naïve patients: Consider non-opioid treatment Prescribe minimum needed for pain 350 MME (50 MME per day for 7 days) limit Ensure a safe transition of care to patients PCP Avoid long-acting opioids
42 Opioid Prescribing for Minors Teens who used opioids for legitimate reasons in high school had a 33% increased risk for future misuse compared to their peers. 1 Consult with pediatrician before prescribing in ED Opioids as last resort for minor injuries Limits the first prescription to a total of 72 MME (24 MME for 3 days) 1 Miech R, Johnston L, O Malley PM, Keyes KM, Heard K. Prescription Opioids in Adolescence and Future Opioid Misuse. Pediatrics. 2015;136(5):e1169-e1177.
43 Opioid Prescribing for Chronic Pain Universal precautions apply Informed Consent, Controlled Substance Treatment Agreement to be repeated annually Requires pain management plans and ongoing assessments of opioid effectiveness Sets a trigger for revaluation at 90 MME Stable patients must be evaluated at least every 90 days Co-prescribe naloxone for prescriptions over 90 MME or if also on benzodiazepines
44 People seek treatment for opioid addiction much sooner after first use than with alcohol Number of admissions Alcohol Opiates Opioids Alcohol 700 Average Elapsed Time 8.2 +/- 7 years /- 12 years Elapsed Time (Years) Between Age of First Use and Age at Treatment Admission for Daily Users of Opioid and Alcohol ( ) Elapsed Time (Years) Source: Alcohol and Drug Abuse Treatment Programs, admissions
45 Effectiveness of Medication Assisted Treatment Several studies have clearly demonstrated MAT is effective across a number of behavioral dimensions compared to placebo or psychological treatment alone: Reduced opioid use (including IVDU) Increased engagement and retention in treatment Reduced morbidity and mortality Improved social functioning Reduced criminal activity Reduced transmission of infectious diseases 45 45
46 Hub and Spoke Model Results for Patients + An established physician-led medical home + A single MAT prescriber + A pharmacy home + Access to existing Community Health Teams + Access to Hub or Spoke nurses and clinicians + Linkages between Hubs and primary care Spoke providers in their areas
47 Vermont has one of the highest rates of treatment capacity Rate of Past Year Opioid Abuse or Dependence* and Rate of Medication Assisted Treatment Capacity with Methadone or Buprenorphine Source: NSDUH Source: N-SSATS *Opioid abuse or dependence includes prescription opioids and/or heroin Source: AJPH 2015; 105(8):e
48 The number of people using heroin at treatment admission is increasing faster than for other opioids Number of people treated in Vermont by substance and Fiscal Year 7,000 Alcohol Marijuana/Hashish Heroin/Other Opioids All Others 6,000 5,000 4,000 3,000 2,000 1, Source: Alcohol and Drug Abuse Treatment Programs
49 While more heroin users inject than prescription drug users, the percent has remained fairly stable Primary Heroin Primary Rx Opiates 80.5% 81.9% 77.2% 75.7% 76.7% 73.1% 72.6% 74.8% 74.6% 76.5% 76.1% 24.8% 21.6% 18.5% 20.7% 21.6% 21.0% 23.3% 24.9% 25.7% 22.2% 23.2% 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Percent of individuals treated for primary diagnosis of opioid misuse who are injection drug users by type of opioid and year Source: Alcohol and Drug Abuse Treatment Programs
50 People Treated for Opioid Abuse or Dependence by Age and Fiscal Year Number of People Treated for Opioid Abuse by Age and Fiscal Year ,839 < , , ,381 1,147 1, Source: Alcohol and Drug Abuse Treatment Programs
51 IV Drug Use at Admission OP/IOP/Residential Treatment 35% 30% 30% 26% 25% 20% 20% 16% 15% 13% 13% 13% 11% 12% 12% 10% 5% Percent of People with IVDU for Primary, Secondary, or Tertiary Substance of Abuse by CY 0% Source: Alcohol and Drug Abuse Treatment Programs 51
52 As the total number of clients in treatment increased, the number of people waiting for services remains flat Census Waiting Jan-14 Feb-14 Mar-14 Number of People in Hubs and Waiting for Hub Services Over Time Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Source: Alcohol and Drug Abuse Treatment Programs 52
53 MAT Evaluation: Preliminary findings Using Vermont Medicaid data, analysis shows: Longer Medication Assisted Treatment corresponds to Individuals with an opioid dependent diagnosis receiving MAT have lower medical care costs than those who have an opioid dependent diagnosis and are receiving non-mat substance abuse treatment lower non-treatment related medical care costs 53
54 Patient functioning at hub discharge Of those completing treatment or transferring to another level of care, 75% show overall improved functioning at discharge Those who leave treatment for other reasons, such as leaving against medical advice, incarceration, or are administratively discharged, only 34% have improved functioning 54
55 55
56 The total number of needles dispensed almost hit 1 million Total number of syringes dispensed by year 999, , , , , ,095 1,200,000 1,000, , , , , Source: Vermont Syringe Exchange Programs 56
57 Vermont Syringe Exchange Programs Provision of sterile syringes and other injection supplies Safe disposal of used syringes (removal of used syringes from the community) Safer sex supplies and education Overdose prevention education and resources Referrals for substance abuse treatment Provision of harm reduction options while injection drug users prepare for or wait for treatment HIV and hepatitis C testing and referrals for follow up medical care if needed Referrals for recommended vaccines 57
58 Administration of Naloxone 58
59 Naloxone Number of doses dispensed by client type, quarter and year New Returning Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Number of reports of naloxone use in response to a perceived overdose incident Jan-Mar 2014 Apr-Jun 2014 Jul-Sep 2014 Oct-Dec 2014 Jan-Mar 2015 Apr-Jun 2015 Jul-Sep 2015 Oct-Dec 2015 Jan-Mar 2016 Apr-Jun 2016 Source: Naloxone Pilot Program 59
60 Improved treatment and screening have helped to identify more infants exposed to opioids Source: Vermont Uniform Hospital Discharge Data Set 60
61 Change in Crimes/100,000 in Vermont Violent Property Murder Forcible Rape Robbery Aggravated Assault Burglary Larceny-Theft Vehicle Theft Federal Bureau of Investigation Uniform Crime Report
62 In Summary Vermont is putting in place many of the prevention, intervention, treatment and recovery options that could help turn the tide on the opioid crisis. Vermont is doing better than much of the country in substance abuse treatment, harm reduction and data collection. While the problem continues to increase, there are small signs of hope: Large parts of the state do not have wait lists for treatment Deaths from prescription opioids appear to be flattening * Naloxone is getting into the hands of those who need it most Youth use is trending downward over time
63 Thank you Source: Harry Chen, M.D.
OPIOID PRESCRIBING RULES. May 17, 2017 Webinar
OPIOID PRESCRIBING RULES May 17, 2017 Webinar Outline Introduction and Universal Precautions Dr. Levine, Commissioner, Health Department 15 Minutes Acute Pain Dr. Patti Fisher, UVMMC 20 Minutes Chronic
More informationStatus of Opioid Treatment Efforts
Status of Opioid Treatment Efforts Health Reform Oversight Committee October 25, 2016 Harry Chen, MD, Commissioner The National Safety Council Categorized Vermont as One of Four States Making Progress
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School
More informationLiterature year in review: Fast take
Literature year in review: Fast take Fatal opioid overdoses have declined in parts of Eastern Mass. By Catie Edmondson GLOBE CORRESPONDENT AUGUST 11, 2017 EMS program called First Watch: Alert to district
More informationThe Impact of the Opioid Crisis. Deborah A. McMahan, MD Health Commissioner Allen County Department of Health
The Impact of the Opioid Crisis Deborah A. McMahan, MD Health Commissioner Allen County Department of Health Agenda How This Mess Started Scope of the Problem Why We Should Care -- Impact How This Mess
More informationIssue Brief Prescription Drug Misuse in Vermont
Issue Brief Prescription Drug Misuse in Vermont STATE EPIDEMIOLOGICAL OUTCOMES WORKGROUP Summary Discrepancies between the perceived problem of prescription drug misuse in Vermont and several pertinent
More informationOctober 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies
October 20, 2016 Scott K. Proescholdbell, MPH Opioid Overdose and North Carolina s Public Health and Prevention Strategies Deaths per 100,000 population Death Rates* for Three Selected Causes of Injury,
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationThe Prescription Drug Overdose Epidemic
The Prescription Drug Overdose Epidemic Rita Noonan, PhD National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division
More informationOpioid Data for Local Governments in North Carolina
Opioid Data for Local Governments in North Carolina Mary Beth Cox, Stacy Taylor, and Adam Lovelady October 10, 2018 Speakers Adam Lovelady Associate Professor UNC School of Government Mary Beth Cox Substance
More informationWhat is the strategy?
What is the strategy? Multi-pronged approaches to reducing the health consequences of opioid use, New York City Northeast Epidemiology Conference Public health approach Track drug use and associated health
More informationOpioid Use and Other Trends
Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis
More informationAddressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention
The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:
More informationThe Opioid Epidemic: The State of the State
JOINT LEGISLATIVE COMMITTEE ON HEALTH AND HUMAN SERVICES The Opioid Epidemic: The State of the State Dr. Mandy Cohen, Dr. Susan Kansagra Department of Health and Human Services Nov. 14, 2017 3 PEOPLE DIE
More informationRule Governing the Prescribing of Opioids for Pain
Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This
More informationReport to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report
Report to The Vermont Legislature Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report In Accordance with Act 179 () Sec. E.306.2 (a)(2) Submitted to: Submitted
More informationOpioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016
1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5
More informationTouchpoints Prior to Opioid Overdose Death
Touchpoints Prior to Opioid Overdose Death 7th Annual BU-CTSI Translational Science Symposium May 3, 2018 Marc Larochelle, MD, MPH Assistant Professor of Medicine Boston Medical Center and Boston University
More informationHigh-Decile Prescribers: All Gain, No Pain?
High-Decile Prescribers: All Gain, No Pain? Len Paulozzi, MD, MPH National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center for Injury Prevention and
More informationVIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC
1 VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC Virginia Association of Counties November 14, 2016 The Honorable William A. Hazel, Jr., M.D. Secretary of Health and Human Resources 1999 - Estimated drug
More informationThe Care Alliance for Opioid Dependence
The Care Alliance for Opioid Dependence The Vermont Hub and Spoke Model John Brooklyn, MD Clinical Assistant Professor of Family Practice and Psychiatry University of Vermont College of Medicine Medical
More informationPutnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationAddressing the Opioid Epidemic in Tennessee
Addressing the Opioid Epidemic in Tennessee A Multidisciplinary Approach Melissa McPheeters, PhD, MPH Director, Informatics and Public Health Analytics 26 108 733 *Source: CDC References Centers for
More informationOpioid Task Force Kick-Off Meeting. February 29, 2016
Opioid Task Force Kick-Off Meeting February 29, 2016 Scope of the Opioid Problem and Data Review Olivia Kasirye, MD, MS County Public Health Officer OVERVIEW The Opioid Epidemic Opioid Task Force Development
More informationOpioid Review and MAT Clinic CDC Guidelines
1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are
More informationThe Opioid Addiction Emergency In Virginia June 8, 2017
The Opioid Addiction Emergency In Virginia June 8, 2017 Marissa J. Levine, MD MPH State Health Commissioner Virginia Department of Health Chronic Disease of Addiction Definition: A primary, chronic disease
More informationBarbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County
County West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report County The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with
More informationAppropriate Opioid Prescribing for Acute Pain after Surgery
Appropriate Opioid Prescribing for Acute Pain after Surgery Richard J. Barth Jr. Professor of Surgery Chief, Section of General Surgery Dartmouth Hitchcock Medical Center American Urologic Association
More informationPrescription Drug Abuse Task Force Rx Report Card
San Diego County Prescription Drug Abuse Task Force 2016 Rx Report Card October 2016 Key Measures of Prescription Drug and Heroin Problems in San Diego County. Visit www.sandiegorxabusetaskforce.org for
More informationMingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationStrategies to Manage The Opioid Crisis
Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor
More informationTrends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville
Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted
More informationRanked in the top 10% in: -Low percent of adults reporting fair or poor health
Marin County ranked in the top 5% in: - Premature death rate - Adults self reported health -Mentally unhealthy days - Adult obesity - Teen birth rate - Uninsured adults - Primary care physicians per capita
More informationWhite Paper on. Prescription Drug Abuse
White Paper on Prescription Drug Abuse October 22, 2014 Table of Contents: I. Introduction II. Scope of the Problem III. Most Common Drugs Involved in Overdoses IV. Efforts in Tennessee V. Prescription
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis
More informationOregon s PDMP: An epidemiological assist tool
Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section
More informationKanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationPrescription Opioid Overdose in Oregon: A public health perspective
Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,
More informationThe Opioid Epidemic: HHS Response
The Opioid Epidemic: HHS Response Christopher M. Jones, PharmD, MPH Acting Associate Deputy Assistant Secretary (Science and Data Policy) Office of the Assistant Secretary for Planning and Evaluation U.S.
More informationPocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationOpioid Deaths in South Carolina. Daniela Nitcheva, PhD Division of Biostatistics Bureau of Public Health Statistics
Opioid Deaths in South Carolina Daniela Nitcheva, PhD Division of Biostatistics Bureau of Public Health Statistics Death Certificates ICD-10 Codes Literal text for cause of death is sent to the National
More informationWashington State s Overdose Epidemic
Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse Institute Affiliate Associate Professor- School of Public Health Affiliate Faculty- Harborview Injury Prevention & Research
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis
More informationBlue Cross of Idaho Addresses State s Opioid Issue
Blue Cross of Idaho Addresses State s Opioid Issue BY THE NUMBERS - Opioid Management page 3 THE PROBLEM - How Preventing Pain Hurt Us page 4 THE SOLUTIONS - Idaho State Board Of Pharmacy Prescription
More informationChad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next
Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics
More informationPrescription Opioid Policies (22 March 2016)
Prescription Opioid Policies (22 March 2016) Prescription opioid misuse and abuse has become problematic in the United States and internationally in economically developed countries. Increased use of opioids
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National
More informationPrescription Opioids: The Real Story 4/30/15
Prescription Opioids: The Real Story 4/30/15 Don Teater MD Medical Advisor National Safety Council Masters student at the UNC Gillings School of Global Public Health Don Teater MD Disclaimer: The information
More informationKentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18
Kentucky s Plan to Address the Opioid Crisis Dr. Katherine Marks Critical Access Hospital Substance Abuse Summit March 8, 2018 2016 National Statistics Deaths per 100,000 population 25 20 15 10 5 Scope
More informationPrescribing Opioids in the Opioid Epidemic. Scott Woffinden, PA-C Jason Chapman, JD
Prescribing Opioids in the Opioid Epidemic Scott Woffinden, PA-C Jason Chapman, JD What's the Problem? http://www.zdoggmd.com/blank-script-taylor-swift-parody/ What's the Problem? CDC 115 Americans die
More informationOPIOID TRENDS IN PIERCE COUNTY. February 2017
OPIOID TRENDS IN PIERCE COUNTY February 2017 Prepared by the Alcohol and Drug Abuse Institute, University of Washington Report written under contract with Tacoma Pierce County Health Department by Caleb
More informationArticle #2 Prescription Drug Overdose CDC: Centers for Disease Control and Prevention. Understanding the Epidemic
Article #2 Prescription Drug Overdose CDC: Centers for Disease Control and Prevention Understanding the Epidemic When the Prescription Becomes the Problem In a period of nine months, a tiny Kentucky county
More informationBree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT
Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter
More informationNorth Carolina, like the rest of the nation, has been experiencing
INVITED COMMENTARY The North Carolina Controlled Substances Reporting System: A Valuable Tool for Combating Prescription Drug Misuse William D. Bronson Prescription drug misuse is a growing problem that
More informationOpioid Overview Admiral Brett P. Giroir, M.D.
A S S I S TA N T S E C R E TA RY F O R H E A LT H Opioid Overview Admiral Brett P. Giroir, M.D. Assistant Secretary for Health Senior Advisor for Opioid Policy @HHS_ASH August 20, 2018 SUBSTANCE ABUSE
More informationIdentification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities
Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,
More informationPolicy and Political Dynamics of the Opioid Addiction Crisis in the United States
Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Mark W. Parrino, M.P.A. July 21, 2018 15 th Annual Midwest Conference on Problem Gambling and Substance Abuse Hilton Kansas
More informationusing analytics to identify and strategically manage patient opioid abuse
using analytics to identify and strategically manage patient opioid abuse Philip Finocchiaro, MD, FACP Senior Medical Director, Quality and Clinical Outcomes Verscend Olivia Mapplethorpe Senior Client
More informationMonthly Data Reports from our Partners. Kayla Donohue, MPH
CommStat 12/20/18 Monthly Data Reports from our Partners Kayla Donohue, MPH 30 Accidental or Undetermined Opioid-Related Fatalities Among Chittenden County Residents, 2010-2017 28 25 20 15 10 5 0 21 20
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More informationState Opioid Response (SOR) Grant
State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics
More informationGreenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationOpiate Use among Ohio Medicaid Recipients
Opiate Use among Ohio Medicaid Recipients July 12, 2012 Ohio Colleges of Medicine Government Resource Center The Ohio State University College of Public Health Sponsored by The Ohio Department of Alcohol
More informationUnintentional Poisonings: Public Health Response Joint Legislative Health Care Oversight Committee
Unintentional Poisonings: Public Health Response Joint Legislative Health Care Oversight Committee Dr. Ruth Petersen Chronic Disease and Injury Section Division of Public Health Oct 12, 2010 In 1999, the
More informationObstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis
Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and
More informationMANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling
MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin
More informationThe Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country
Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin
More informationOpioid Management of Chronic (Non- Cancer) Pain
Optima Health Opioid Management of Chronic (Non- Cancer) Pain Guideline History Original Approve Date 5/08 Review/Revise Dates 11/09, 9/11, 9/13, 09/15, 9/17 Next Review Date 9/19 These Guidelines are
More informationAppropriate Opioid Prescribing for Acute Pain after Surgery
Appropriate Opioid Prescribing for Acute Pain after Surgery Richard J. Barth Jr. Professor of Surgery Chief, Section of General Surgery Dartmouth Hitchcock Medical Center Clinical Trials Network Webinar
More information6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES
First Do No Harm Implementing an Opioid Stewardship Program in a HealthCare System Phil Chang, MD Kristy Deep, MD Doug Oyler, PharmD June 12, 2017 OBJECTIVES Explain the role of opioid stewardship as a
More informationIntroduction to the NC ED Pain Management Guidelines. April 12, 2017
Introduction to the NC ED Pain Management Guidelines April 12, 2017 Our Agenda Overview of Opioid Epidemic Our Committee Efforts Review of NC ED Pain Management Guidelines NCHA Grant Overview 2 Polling
More informationPain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN
Pain Management and Safe use of opioids in hospitals Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Bronx Care Health System Bronx Lebanon Hospital Concourse/ Fulton division, Nursing
More informationMay 25, Drug Overdose Update & Response: Combatting Opioid Overdose
May 25, 2017 Drug Overdose Update & Response: Combatting Opioid Overdose Overview The Problem -Overdose in North Carolina (and a little nationally) -Other associated health threats PDAAC-NC s Response
More informationReversing America s Opioid Epidemic. August 2017
Reversing America s Opioid Epidemic August 2017 Goals of presentation Discuss national and regional opioid-related mortality and prescribing trends Highlight national and state legislative and other policy
More informationMobilizing a Response to the Opioid Epidemic: County Snapshots. Kelly Pfeifer, MD May 10, 2018
Mobilizing a Response to the Opioid Epidemic: County Snapshots Kelly Pfeifer, MD kpfeifer@chcf.org May 10, 2018 Housekeeping All lines are muted This session will be recorded To ask a question: Questions
More informationPrescription Drug Abuse National Perspective
Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible
More informationThe Morbidity and Mortality of Kansas Drug Epidemic
The Morbidity and Mortality of Kansas Drug Epidemic Fan Xiong, MPH Senior Epidemiologist Kansas Board of Pharmacy Kansas Data-Driven Prevention Initiative Program Kansas Department of Health and Environment,
More informationUnderstanding and Combating the Heroin Epidemic
Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the
More informationDrugs in the Workforce: The Rise of Prescription Opioid Use and Abuse. Don Teater MD
Drugs in the Workforce: The Rise of Prescription Opioid Use and Abuse Don Teater MD Don Teater MD Medical Advisor National Safety Council Medical Provider Mountain Area Recovery Center Asheville, NC Medical
More informationFacing the Opioid Epidemic (FOE): Assessing and Responding to Prescription and Illicit Opioid Use and Misuse in 5 New England States
Facing the Opioid Epidemic (FOE): Assessing and Responding to Prescription and Illicit Opioid Use and Misuse in 5 New England States T h o m a s J. S t o p k a, P h D, M H S L e o B e l e t s k y, J D,
More informationSC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC
SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a
More informationHHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder
HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder Brett Giroir, U.S. Department of Health and Human Services Join the conversation at #OUDTreatment #EndTheStigma Expanding
More informationCDC s Approach to Addressing the Opioid Overdose Epidemic
CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths
More informationReducing opioid overdose mortality: role of communityadministered
Reducing opioid overdose mortality: role of communityadministered naloxone Vennus Ballen, MD, MPH; Lara Maldjian, MPH New York City Department of Health and Mental Hygiene Clinical Director s Network (CDN)
More informationThe Role of the Emergency Department in the Opioid Epidemic. Scott G. Weiner, MD, MPH Department of Emergency Medicine Brigham and Women s Hospital
The Role of the Emergency Department in the Opioid Epidemic Scott G. Weiner, MD, MPH Department of Emergency Medicine Brigham and Women s Hospital Disclosures Treasurer, Massachusetts College of Emergency
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationNM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 218 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau
More informationOpioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative
Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division
More informationPrescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017
Prescription Drug Monitoring Program Update Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017 Objectives Brief historical overview of opioids Review of PDMP information Discuss ideas from
More informationThe Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division
The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able
More informationTop 10 narcotic pain pills
Top 10 narcotic pain pills Click to go to the item or just scroll down the page. Doctors Respond to FDA Panel Recommendations FDA Considers Banning Popular Prescription Pain Medications and. Top 10 Natural
More informationTargeting an Epidemic: Opioid Prescribing Patterns by County in New York State
Targeting an Epidemic: Opioid Prescribing Patterns by County in New York State DECEMBER 2017 Improving the state of New York s health Background O pioid abuse is a public health crisis for the nation and
More informationApproved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina
Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina Robert B. Hanlin, M.D., FAAFP Vice Chair, Medical Staff Affairs Greenville Health System Greenville, SC Disclosures
More informationControlled Substance Prescribing Trends and Odds of Drug Overdose Death
Controlled Substance Prescribing Trends and Odds of Drug Overdose Death Christina Holt, MD, MSc 1, Kenneth McCall, PharmD 2 Gary Cattabriga, BA 3, Emily Bourret, PharmD 2, Chunhao Tu, PhD 2 ; Christian
More informationFrom Medicaid Transformation Approved Project Toolkit, June 2017
From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate
More informationTennCare s Opioid Strategy
TennCare s Opioid Strategy Benjamin S. Heavrin, MD, MBA, FACEP Associate Medical Director State of Tennessee Division of TennCare Rural Health Association of Tennessee 24 th Annual Conference November
More informationOpioid Overdose in Oregon Report to the Legislature
SEPTEMBER 2018 Opioid Overdose in Oregon Report to the Legislature This report summarizes the burden of opioid overdose among Oregonians as required by ORS 432.141. It describes Oregon s progress in reducing
More information